Quick Answer
KIORA PHARMACEUTICALS INC reported R&D Expense of $10.78 million for fiscal year 2025.
KIORA PHARMACEUTICALS INC R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $10.78M | +37.5% |
| 2024 | $7.84M | +94.7% |
| 2023 | $4.03M | +16.8% |
| 2022 | $3.45M | -35.5% |
| 2021 | $5.35M | +50.0% |
| 2020 | $3.57M | -33.8% |
| 2019 | $5.39M | -33.1% |
| 2018 | $8.06M | -22.0% |
| 2017 | $10.33M | +22.7% |
| 2016 | $8.42M | +210.0% |
| 2015 | $2.72M | +411.6% |
| 2014 | $531.1K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.73M | +24.9% | +5.4% |
| June 30, 2025 | $2.59M | +26.4% | +2.3% |
| March 31, 2025 | $2.53M | +50.3% | +15.9% |
| September 30, 2024 | $2.18M | +101.4% | +6.7% |
| June 30, 2024 | $2.05M | +47.2% | +21.6% |
| March 31, 2024 | $1.68M | +284.3% | +55.2% |
| September 30, 2023 | $1.09M | -18.6% | -22.1% |
| June 30, 2023 | $1.39M | +145.4% | +217.6% |
- KIORA PHARMACEUTICALS INC showed an increase of +37.5% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, KIORA PHARMACEUTICALS INC’s r&d expense has grown by 1929.8% (from $531.1 thousand to $10.78 million).
- The most recent figure is from KIORA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: